Home / Conditions / Temporomandibular Joint Disorder
Temporomandibular Joint Disorder: when insurers say no, reviewers often say yes
In 48 published external-review decisions involving temporomandibular joint disorder, independent physician reviewers overturned the insurer’s denial 41.7% of the time.
Published decisions
48
2001–2026
Overturned
41.7%
20 denials reversed
Most-fought treatments for temporomandibular joint disorder
What insurers denied — and how those fights ended.
| Treatment | Decisions | Overturned |
|---|---|---|
| Botox Injections | 13 | 38.5% |
What the insurer actually argued
Denials fall into different categories, and they don’t succeed equally — so the reason on your letter changes how you should answer it.
| Reason given | Decisions | Overturned |
|---|---|---|
Medical Necessity The plan said the care wasn’t medically necessary. The most common fight, and the most winnable. | 32 | 53.1% |
Experimental/Investigational The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument. | 15 | 20% |
Typical time to a decision
20 days
Most land between 13 and 22 days
Handled as urgent
20.8%
Expedited when a delay would cause harm
What the reviewers wrote
Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.
Where the denial was overturned
Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for facial Botox injections. Mehta and colleagues note that temporomandibular disorders (TMD) are associated with substantial morbidity, affecting quality of life and work productivity, and that the goals of TMD management are to alleviate pain and to improve jaw function and quality of life. The authors further explain that standard noninvasive management includes self-care and education, physical therapy, occlusal splints, behavioral therapy, and adjunctive pharmacotherapy, while for patients with TMD symptoms refractory to noninvasive management, treatment options may include trigger point muscle injections, botulinum toxin injections, intra-articular injections, or, in some patients, surgery such as arthrocentesis, arthroscopy, arthroplasty, or temporomandibular joint (TMJ) reconstruction.…
Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: The patient has requested reimbursement for orthognathic surgery (reconstruction of midface, LeFort, bilateral sagittal split osteotomy, segmental osteotomy, with genioglossus advancement, septoplasty, excision inferior turbinate, oral surgical splint, virtual surgical planning, and maxillomandibular fixation). As noted by the Researchers“The surgical correction of maxillofacial skeletal deformities includes the reconstructive procedures that correct deformities of the maxilla, mandible, facial skeleton, and associated soft tissue structures.” Further, the AAOMS noted that “The principal goal for surgical correction of the maxillofacial skeletal deformity is to create or restore normal form, function, and health, while minimizing potential negative short-term and long-term sequelae.” On review of the r…
Where the denial was upheld
Worth reading too — these show what an appeal has to overcome.
Nature of Statutory Criteria/Case Summary: An enrollee has requested authorization and coverage for Botox injections. There is a lack of controlled studies, single or double-blind, that prove the efficacy of botulinum toxin used in the treatment of temporomandibular joint disorders. Temporomandibular joint disorders represent a complex and multifaceted set of conditions affecting the jaw joint and muscles controlling jaw movement. The treatment for temporomandibular joint disorders varies, ranging from conservative therapies to surgical interventions. Botulinum toxin, primarily known for its use in cosmetic procedures, has been explored as a treatment for temporomandibular joint disorders. The use of botulinum toxin in temporomandibular joint disorders is predicated on its ability to reduce muscle activity, thereby alleviating pain and dysfunction.
Nature of Statutory Criteria/ Case Summary: The enrollee is requesting reimbursement and authorization and coverage for Botulinum toxin (Botox) injections. The enrollee has diagnoses of gingival recession, limited range of motion, temporomandibular joint (TMJ) disorders, sleep-related bruxism, muscle spasm, atypical facial pain, myofascial pain, headache and dystonia. The enrollee has been treated for painful bruxism, which has been causing persistent facial pain, dystonia, and headaches. She has demonstrated improvement, indicating the treatments have been effective in alleviating pain due to bruxism. The enrollee notes she has nighttime teeth clenching, in addition to bruxism with no evidence she grinds her teeth. Most of the pain she has experienced from clenching her teeth, which is involuntary, occurs during the day.
Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California outcomes — every state runs an equivalent external review, but the rates here are California’s. Excerpts are quoted verbatim from the public record and describe this condition generally, not any individual case.
How to use this in your appeal
These outcomes come from California’s external review program — an independent physician panel whose decision binds the insurer. Every state has an equivalent, and internal appeals succeed even more often. If your care for temporomandibular joint disorder was denied, the published record says the denial is worth fighting.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY
Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.